Abstract:Background Overall mortality in ANCA-associated vasculitis (AAV) over the last two decades has been reported to be decreasing with the use of immunosuppressive therapies. However, mortality rates remain high and most of the deaths occur in the first year after diagnosis despite treatment. Objectives In this study, we aimed to determine the prevalence of mortality in our AAV patients and to investigate the factors that may be associated with first-year and overall mortality. Methods Patients followed up in one center with the diagnosis of AAV were included in the study. Diagnostic subgroups were; granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA), and renal-limited vasculitis (RLV). The clinical and demographic characteristics of the patients were collected retrospectively. Factors predictive of mortality were evaluated by Kaplan-Meier method and the Cox proportional hazard model. Results In total 104 (45 [43%] female and mean age 54.9 ± 15.4 years) AAV patients (51 GPA; 25 MPA; 27 RLV and 1 EGPA) were included in the analysis. ANCA positivity was detected in 81 (77.9%) patients with IIF and/or ELISA. ESRD had developed in 31 (32.3%) of AAV patients and in 37.8% of patients with renal involvement. Mortality rate was 14.4% in the first year after diagnosis and 27.9% during a median follow-up period of 1289 (5-5804) days. The age at diagnosis was the only significant predictor of first-year mortality (p=0.006). Univariate analysis revealed that overall mortality was associated with AAV subgroups (p = 0.035), renal (p = 0.046) (figure) and, ENT (ear-throat) involvement (p = 0.025), ESRD (p = 0.025) and hemodialysis at the time of diagnosis (p = 0.040). However Cox regression analysis showed age at diagnosis as the only significant predictor also of the overall mortality (P=0,001). Conclusion Our findings suggest that there could be some survival differences between AAV subgroups and patients with or without renal and ENT involvement. However, the age at diagnosis seems to be the only significant predictor of first-year and overall mortality in our AAV patients. Figure. The results of the Kaplan-Meier analysis. Overall mortality was significantly associated with renal involvement (a) and AAV subgroups (b). *AAV: ANCA-Associated Vasculitis; GPA: Granulomatosis with PolyAngiitis; MPA: Microscopic PolyAngiitis; RLV: Renal Limited Vasculitis Disclosure of Interests Onay Gercik: None declared, Zeki Soypacaci: None declared, Fulya Çakalağaoğlu: None declared, Gokhan Kabadayi: None declared, Idil Kurut: None declared, Dilek Solmaz: None declared, Servet Akar Grant/research support from: MSD, Abbvie, Roche, UCB, Novartis, Pfizer, Amgen, Consultant for: MSD, Abbvie, Roche, UCB, Novartis, Pfizer, Amgen, Speakers bureau: Pfizer

FRI0293 FACTORS ASSOCIATED WITH FIRST-YEAR AND OVERALL MORTALITY IN ANCA ASSOCIATED VASCULITIS; PATIENTS WITH RENAL LIMITED VASCULITIS MAKES NO BETTER THAN MICROSCOPIC POLYANGIITIS

Predictors for Mortality in Patients with Antineutrophil Cytoplasmic Autoantibody-associated Vasculitis: A Study of 398 Chinese Patients

The risk factors for early mortality and end-stage renal disease in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: experiences from a single center

Clinical Predictors of Outcome in Patients with Anti-neutrophil Cytoplasmic Autoantibody-related Renal Vasculitis: Experiences from a Single-center.

Predictors of Poor Prognosis in ANCA-associated Vasculitis (AAV): a Single-Center Prospective Study of Inpatients in China

The Survival Nomograms for Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis Patients with a Follow-Up of More Than One Year.

Analysis of the risk factors for end‑stage renal disease and mortality in ANCA-associated vasculitis: a study from a single center of the Chinese Rheumatism Data Center

Predictors for Outcomes in Patients with Severe ANCA-associated Glomerulonephritis Who Were Dialysis-dependent at Presentation: A Study of 89 Cases in a Single Chinese Center

Prognosis and Risk Factors of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients on Maintaining Dialysis

Long-Term Prognostic Factors in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A 15-Year Multicenter Retrospective Study

Pathological Classification and Prognosis of Renal Damage Caused by Antineutrophil Cytoplasmic Antibody Associated Vasculitis

Clinical Characteristics and Prognosis in 269 Patients with Antineutrophil Cytoplasimc Antibody Associated Vasculitis.

Association Between Different Infection Profiles and One-Year Outcomes in ANCA-associated Vasculitis: a Retrospective Study with Monthly Infection Screening

Analyzing Fatal Cases of Chinese Patients with Primary Antineutrophil Cytoplasmic Antibodies-Associated Renal Vasculitis: a 10-Year Retrospective Study.

A predictive mortality score in ANCA-associated renal vasculitis

The impact of intravenous methylprednisolone pulses on renal survival in anti-neutrophil cytoplasmic antibody associated vasculitis with severe renal injury patients: a retrospective study

The Outcomes Of Patients With Esrd And Anca-Associated Vasculitis In Australia And New Zealand

Clinical characteristics and prognosis of ANCA-associated vasculitis in patients with renal injury

Predictors of Mortality in Critically Ill Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Long-term outcome of kidney function in patients with ANCA-associated vasculitis

Performance of clinical and histological prognostic scores for kidney survival in ANCA-associated vasculitis